Unjha Formulations Surges to 52-Week High, Outperforming Sector and Market Averages

Unjha Formulations, a microcap pharmaceutical company, has recently seen a surge in its stock price, reaching a 52-week high on November 5th, 2024. The stock has been performing well in the market, with a 'Hold' call from MarketsMOJO. On November 5th, the stock hit a new 52-week and all-time high of Rs. 37.03, outperforming the sector by 5.03%. It has also been on a consecutive gain for the last 3 days, with a 23.33% increase in returns during this period. The stock opened with a gain of 2.74% today and touched an intraday high of Rs. 37.03, a 5.68% increase. Unjha Formulations is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in the market. In the past year, the company has shown a strong performance with a 93.54% increase, while the Sensex has only seen a 22.30% increase. As a microcap company in the pharmaceutical industry, Unjha Formulations has been making strides in the market with its consistent growth and positive performance. With a 'Hold' call from MarketsMOJO, investors may want to keep an eye on this stock as it continues to show promising results.